← Open Payments lookup

BRENDAN GREENAWAY: Open Payments

NPI 1841632072 · BEVERLY HILLS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,329 in 50 payments from 15 companies in 2025. Trend: 2023 $483 · 2024 $1,261 · 2025 $1,329

Food & beverage: $1,329
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.8$276
Axsome Therapeutics, Inc.7$254
ABBVIE INC.10$221
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)7$155
Noven Therapeutics, LLC3$73
Vanda Pharmaceuticals Inc.2$60
Takeda Pharmaceuticals U.S.A., Inc.3$57
Collegium Pharmaceutical, Inc.2$45
Bausch Health US, LLC2$43
Lundbeck LLC1$32

Products named: INGREZZA, Auvelity, VRAYLAR, CAPLYTA, Xelstrym, REXULTI, TRINTELLIX, Jornay PM.

Industry payments across CA — which companies pay providers there.